Literature DB >> 6538493

High-dose cytosine arabinoside therapy in acute non-lymphocytic leukemia.

H D Preisler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6538493     DOI： 10.1016/0277-5379(84)90201-3

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN： 0277-5379


× No keyword cloud information.
  4 in total

Review 1.  Drug treatment of acute leukaemia. Current status.

Authors:  S M Donohue; C P Charlton
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

2.  Non-cardiogenic pulmonary edema complicating intermediate and high-dose Ara C treatment for relapsed acute leukemia.

Authors:  U Jehn; N Göldel; R Rienmüller; W Wilmanns
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

3.  Limited efficacy of a four-day course of high-dose cytosine arabinoside in the treatment of poor-risk patients with acute nonlymphocytic leukemia.

Authors:  H D Preisler; A Raza; R Larson; G Browman; J Goldberg; H Grunwald; R Vogler; J Bennett; A Gottlieb; P D'Arrigo
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Uphill transport of pyrimidine nucleosides in renal brush border vesicles.

Authors:  M Le Hir; U C Dubach
Journal:  Pflugers Arch       Date:  1985-07       Impact factor: 3.657
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.